GA: Pharma Firm Boehringer Ingelheim to Expand Animal Health Center in Athens, Adding 55 Jobs | Trade and Industry Development

GA: Pharma Firm Boehringer Ingelheim to Expand Animal Health Center in Athens, Adding 55 Jobs

Share
Apr 25, 2022
Global pharmaceutical development and manufacturing company Boehringer Ingelheim will expand its Animal Health Global Innovation center in Athens, Georgia.

Global pharmaceutical development and manufacturing company Boehringer Ingelheim will expand its Animal Health Global Innovation center in Athens, Georgia. The $57 million investment will increase laboratory space and bring additional research and development capabilities and activities, including 55 new positions, to the site, reports the publication All On Georgia.

“Boehringer Ingelheim has been a fantastic member of our Georgia Life Sciences community, and we are so excited to see them continue to choose Georgia to grow,” said Governor Kemp. “Georgia’s university system provides the talent life science companies want, and our pro-business environment combined with our commitment to innovation continues to create opportunities for hardworking Georgians across the state.”

As a research-driven pharmaceutical company, Boehringer Ingelheim, based in Germany, focuses on three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. The company manufactures widely used vaccines, parasite-control products, and therapeutics for pets, horses, and livestock, reports All On Georgia.

“Our new and expanded space has been specifically designed to encourage closer connections between teams and colleagues. After working in a distanced or virtual manner for so many months, we all have a much greater appreciation for the power of both formal and spontaneous collaboration,” explained Caroline Belmont, US Head of Global Innovation. “The significant investment in expanding and enhancing our Athens Global Innovation site will provide not only a comfortable and flexible physical space that inspires collaboration, but also will bring many new tools and technologies to spark the innovation that will ultimately help improve animal and human wellbeing.”

Construction began recently on a new 63,000-square-foot facility, located at 1730 Olympic Drive in Athens, that will connect two existing buildings currently housing laboratory and administrative space, along with a 5,000-square-foot expansion and partial renovation of existing Global Innovation facilities in Athens. The new facility is slated to be complete in spring 2024. When complete, the expansion will bring Boehringer Ingelheim’s Global Innovation footprint in Athens to nearly 115,000 square feet and accommodate an additional 55 research and development positions at the site.

(Click to Expand)